Eric Lang

Eric Lang is an accomplished scientist with extensive experience in medicinal chemistry and molecular modeling. With a career spanning roles such as Medicinal Chemist at Novartis and GSK, and currently serving as Associate Principal Scientist at AstraZeneca, Eric has successfully contributed to the development of potential treatments for cancer and Alzheimer's disease. Academic qualifications include a PhD in Chemistry from the University of Canterbury and multiple master's degrees in chemistry and technology management. Eric has also held positions in marketing management at Novasep and provided consultancy in molecular modeling to a start-up focused on in-silico drug discovery.